IFNG and cancer: In an immunotherapy context, the results could support the notion that, for a tumor in which an increase in cancer cell PD-L1 expression is mediated through T-cell-secreted IFN-γ, the PD-L1 methylation level will not be a marker of actual PD-L1 expression.